Results 81 to 90 of about 8,552 (153)

Tumor-Induced Osteomalacia in a Patient With FGF23-Amplified Lung Adenocarcinoma and FGF23-Deleted SCLC: Case Report

open access: yesJTO Clinical and Research Reports
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by ectopic fibroblast growth factor-23 (FGF23) production. We report a unique case of a 78-year-old female patient with refractory hypophosphatemia, ultimately diagnosed as ...
Marcello Moro Queiroz, MD   +13 more
doaj   +1 more source

Deletion of cardiac fibroblast growth factor-23 beneficially impacts myocardial energy metabolism in left ventricular hypertrophy

open access: yesnpj Metabolic Health and Disease
Left ventricular hypertrophy (LVH) is associated with increased cardiac expression of fibroblast growth factor-23 (FGF23) in mice and men. To further elucidate the role of cardiac FGF23 in LVH, we specifically ablated Fgf23 in cardiomyocytes, and ...
Nejla Latic   +13 more
doaj   +1 more source

FGF23C-tail improves diabetic nephropathy by attenuating renal fibrosis and inflammation

open access: yesBMC Biotechnology, 2018
Background High level of serum fibroblast growth factor 23 (FGF23) is implicated in the development and progression of diabetic nephropathy (DN), making it a crucial factor in the pathogenesis of DN.
Xiaomin Zhang   +5 more
doaj   +1 more source

Phosphaturic mesenchymal tumor of the nasal cavity: Clinicopathologic correlation is essential for diagnosis

open access: yesHuman Pathology: Case Reports, 2019
Phosphaturic mesenchymal tumor (PMT) is a rare neoplasm in which the tumor cells produce fibroblast growth factor 23 (FGF23), leading to oncogenic osteomalacia and thus a distinct clinical presentation.
Aidan Kerr   +5 more
doaj   +1 more source

Studies on the regulation of the phosphaturic hormone fibroblast growth factor 23 (FGF23)

open access: yes, 2019
Fibroblasten-Wachstumsfaktor 23 (FGF23) ist ein aus dem Knochen stammendes Hormon, das den Blutspiegel von Phosphat und aktivem Vitamin D reguliert. Bei diversen menschlichen Erkrankungen, wie Nieren- oder Herz-Kreislauf-Erkrankungen, ist der FGF23-Spiegel verändert, wodurch es auch seine klinische Relevanz erlangt.
openaire   +2 more sources

Both enantiomers of β-aminoisobutyric acid BAIBA regulate Fgf23 via MRGPRD receptor by activating distinct signaling pathways in osteocytes

open access: yesCell Reports
Summary: With exercise, muscle and bone produce factors with beneficial effects on brain, fat, and other organs. Exercise in mice increased fibroblast growth factor 23 (FGF23), urine phosphate, and the muscle metabolite L-β-aminoisobutyric acid (L-BAIBA),
Eijiro Sakamoto   +9 more
doaj   +1 more source

Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor-Induced Osteomalacia. [PDF]

open access: yesJBMR Plus, 2022
Hartley IR   +11 more
europepmc   +1 more source

Research progress on the biological role of serum soluble α-Klotho in chronic kidney diseases

open access: yesLinchuang shenzangbing zazhi, 2020
α-Klotho is an anti-aging protein, which has been reported to bind with fibroblast growth factor receptor-1(FGFR1) to become a transmembrane co-receptor of fibroblastic growth factor-23(FGF23), thereby mediating FGF23/FGFR1/Klotho signaling to play a key
SUN Long   +5 more
doaj  

Organic phosphate but not inorganic phosphate regulates Fgf23 expression through MAPK and TGF-ꞵ signaling

open access: yesiScience
Summary: One of the main regulators of phosphate homeostasis is fibroblast growth factor 23 (FGF23), secreted by osteocytes. The effects of organic versus inorganic dietary phosphate on this homeostasis are unclear.
Danielle M.A. Ratsma   +5 more
doaj   +1 more source

Fibroblast growth factor 23 (FGF23) [PDF]

open access: yesScience-Business eXchange, 2011
openaire   +1 more source

Home - About - Disclaimer - Privacy